Pancreatic carcinoma in perspective. A continuing challenge

Area of Science:

• Gastroenterology and Oncology
• Molecular Biology

Background:

• Pancreatic cancer affects approximately 27,000 individuals annually, with a high mortality rate.
• While smoking is a risk factor, chronic pancreatitis can precede a subset of pancreatic cancers.
• The disease predominantly impacts pancreatic ducts, with c-K-ras mutations (80%) and p53 (60-80%) being key molecular events.

Purpose of the Study:

• To review current understanding and management of pancreatic cancer.
• To highlight diagnostic modalities and treatment strategies.
• To emphasize the importance of clinical trials for advancing patient outcomes.

Main Methods:

• Review of current diagnostic techniques including thin-slice computed tomography, portography, and endoscopic retrograde cholangiopancreatography.
• Evaluation of emerging detection methods like endoscopic ultrasound and laparoscopy.
• Analysis of treatment outcomes including surgical resection and palliative bypass procedures.

Main Results:

• Jaundice is a common symptom for cancers in the pancreatic head.
• Advanced imaging techniques enhance early detection capabilities.
• Curative resection is feasible in 10-15% of selected patients, with survival rates varying based on stage and surgical expertise.

Conclusions:

• Early detection and appropriate patient selection are critical for improving survival in pancreatic cancer.
• Palliative endoscopic bypass can mitigate the need for surgery in advanced cases.
• Participation in clinical trials is essential for advancing treatment efficacy and patient outcomes.